Sort By

  • Newest

  • Newest

  • Oldest

  • Author Name

  • Author Name

  • David Chaplin

  • Drew Meredith

  • Giselle Roux

  • Greg Bright

  • Ishan Dan

  • James Dunn

  • Lachlan Maddock

  • Owen Raszkiewicz

Retiree love affair with Telstra dividends on display again

Company results are all about meeting investor expectations. So, despite a falling profit, Telstra shares were in demand yesterday while Cochlear, which posted a 27 per cent increase in earnings, found investors had a tin ear after the group forecast a slower 2025.

Drew Meredith | 16th Aug 2024 | More
BHP losses fuel worst week for ASX since January

Losing week, iron ore and the economy, Cochlear tanks The ASX200 (ASX: XJO) fell another four points on Friday, capping a full week of lower closes and a loss of 2.2% for the five days. On Friday, it was all about Cochlear (ASX: COH) with the hearing aid manufacturer falling 7.4% despite recording record sales of $1.49 billion and a 54%…
The Inside Investor | 22nd Aug 2021 | More
After watershed year for biotechs, diversification is key

2020 was a watershed year for biotech companies around the world. The combination of urgent need, commitment and massive government support saw the huge benefits of research and development on show, when not one but multiple companies produced vaccines for the Coronavirus. Extensive coverage of the sector generated huge enthusiasm for it, with many stocks…
Staff Writer | 10th Mar 2021 | More